Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ARTMS logo — Accelerating Solid Targetry For Medical Isotope Production....

ARTMS

Accelerating Solid Targetry For Medical Isotope Production. A Telix Group company

Founded 2013 Canada Canada 28 employees Grant Total: $22.30M Health Care, Information Technology

General Information

Company Name ARTMS
Founded Year 2013
Location Canada Canada +1
Founders / Decision Makers
Team member
Employees 28
Industries Health Care, Information Technology
Funding Stage Grant
Social

Get notified when ARTMS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ARTMS

ARTMS is a Canadian startup that specializes in the physics, chemistry, and materials science of cyclotron-produced radionuclides. Their core technology platform, the QUANTM Irradiation System™ (QIS™), supports high efficiency, large-scale, and cost-effective production of commercially important medical isotopes such as zirconium-89 (89Zr), gallium-68 (68Ga), technetium‐99m (99mTc), and copper-64 (64Cu). It is used by major manufacturing networks to optimize production of a range of medical radioisotopes. Recently, the company was acquired by Telix Pharmaceuticals.

Founded in 2013, ARTMS operates in the Health Care and Information Technology industries. In March 2021, the company received a $300.00K grant investment from Innovate BC.

Taxonomy: ARTMS, Telix Pharmaceuticals, medical isotopes, QUANTM Irradiation System, isotope production, cyclotron-produced radionuclides, zirconium-89, gallium-68, technetium‐99m, copper-64, radiopharmaceuticals, nuclear medicine, oncology, cardiology, neurology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 02 Mar 2021
Series A •••••• 2 •••• •••• 20 May 2020
Venture Round •••••• 2
Investor Investor
18 Dec 2017

ARTMS Alternatives & Competitors

ARTMS vs
Advanced Cyclotron Systems Inc.
Advanced Cyclotron Systems Inc. Canada

Outperforming the field

42 employees
Manufacturing, Medical Devices
Compare ARTMS vs Advanced Cyclotron Systems Inc.
ARTMS vs
IQ Medical Services
IQ Medical Services United States

In-House consulting services for the Nuclear Medicine industry

34 employees
Analytics, Health Care
Compare ARTMS vs IQ Medical Services
ARTMS vs
Open Medscience
Open Medscience United Kingdom

Open Medscience is a blog and journal to discuss a range of medical imaging modalities.

1 employees
Health Care
Compare ARTMS vs Open Medscience

FAQ About ARTMS

Accelerating Solid Targetry For Medical Isotope Production. A Telix Group company
ARTMS was founded in 2013.
ARTMS is headquartered in Canada.
ARTMS operates in the following industries: Health Care, Information Technology.
ARTMS has approximately 28 employees.
ARTMS has completed 3 funding rounds, raising a total of $22.30M. The latest funding stage is Grant.
Top alternatives and competitors to ARTMS include Advanced Cyclotron Systems Inc., IQ Medical Services, Open Medscience , polySpectra, ABT Molecular Imaging. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ARTMS and Advanced Cyclotron Systems Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ARTMS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy